Arcus Biosciences develops late-stage immunotherapies, with Domvanalimab and Casdatifan leading the way. See why I rate RCUS ...

JTL Industries jumped 5.96% to Rs 233 after the company's board will meet on 3 October 2024 to consider sub-division/split of equity shares having face value of Rs 2 each.

Alzheimers and Dementia Society Chairperson, Jeanette Ochello, has thanked everyone who took part in the weekend's Memory ...

New management simulation game TCG Card Shop Simulator is exploding on Steam, as it hits 'overwhelmingly positive' after just ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Gilead’s twice-yearly injection for HIV prevention cut infections by 96% in a late-stage trial, the company said Thursday, ...

Shares of Donald Trump's media company fell for a second session on Tuesday ahead of the end of restrictions on share sales ...

In a report released yesterday, Justin Zelin from BTIG maintained a Buy rating on Viking Therapeutics (VKTX – Research Report), with a ...

The Tirupati Laddu, an iconic prasad of the Tirumala Venkateswara Temple, in Andhra Pradesh has a rich history that goes back ...

The Agricultural and Processed Food Products Export Development Authority (APEDA), which is responsible for the export ...

JTL Industries Limited has significantly expanded its production capacity with the successful commissioning of its new ...

This post was written by Naomi Buchanan. As US stock continue their rate cut-fueled rally, Evercore ISI senior managing director of equity, derivatives, and quantitative strategy Julian Emanuel, joins ...